中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
  • 合肥物质科学研究院 [36]
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共36条，第1-10条 帮助

限定条件                
条数/页： 排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文  OAI收割
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
  |  收藏  |  浏览/下载：16/0  |  提交时间：2023/11/10
Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography 期刊论文  OAI收割
BMC CANCER, 2022, 卷号: 22
作者:  Peng, Chanjuan;  Yi, Dan;  Zhou, Ying;  Yao, Jincao;  Chen, Bo
  |  收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry 期刊论文  OAI收割
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 卷号: 15
作者:  Liu, Long;  Yu, Xingxing;  Li, Zhifeng;  He, Xiaohua;  Zha, Jie
  |  收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23
The Prognostic Utility of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients 期刊论文  OAI收割
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Li, Cong;  Yu, Haifeng;  Chen, Xi;  Han, Shuiyun;  Peng, Shuailing
  |  收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文  OAI收割
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan
  |  收藏  |  浏览/下载：71/0  |  提交时间：2022/12/22
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文  OAI收割
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
  |  收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文  OAI收割
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
  |  收藏  |  浏览/下载：51/0  |  提交时间：2022/05/05
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2 期刊论文  OAI收割
LEUKEMIA, 2022
作者:  Yang, Jing;  Weisberg, Ellen L.;  Qi, Shuang;  Ni, Wei;  Mei, Husheng
  |  收藏  |  浏览/下载：68/0  |  提交时间：2022/02/14
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文  OAI收割
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao
  |  收藏  |  浏览/下载：55/0  |  提交时间：2022/02/14
Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial 期刊论文  OAI收割
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Liu, Hailing;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli
  |  收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23